Home - Gastroenterology Advisor
WEBGI and Liver Disease in Pregnancy: AGA Clinical Practice Updates. By Colby Stong. The American Gastroenterological Association has released new guidance on the clinical management of pregnancy-related gastrointestinal and liver disease.
Clinician Insights on How to Manage Semaglutide-Induced …
WEBSep 8, 2023 · Patients who receive treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, such as semaglutide, may experience delayed gastric emptying due to the drug’s mechanism of action (MOA). 1 Symptoms may include nausea, vomiting, heartburn, pain, or bloating. 2 However, the symptoms of delayed gastric emptying resulting from GLP-1 receptor agonists may be similar to symptoms of ...
What We Know About Semaglutide Adverse Events and …
WEBSep 1, 2023 · What Are Other Causes of Gastroparesis? Diabetes is the most common underlying cause of gastroparesis and can damage the vagus nerve, leading to impaired muscular function in the stomach and small intestine. 3 Studies show that the 10-year cumulative incidence of diabetic gastroparesis is estimated to be 5.2% among patients with type 1 diabetes and 1% in patients with type 2 diabetes. 4
Endoscopic Remission in UC Best Achieved With Upadacitinib
WEB3 days ago · The interventions that were best at maintaining endoscopic remission were upadacitinib (SUCRA, 87.1%) and etrasimod upadacitinib (SUCRA, 77.7%). For the outcome of histological remission, all biologic and small molecule therapies were more efficacious than placebo, except for adalimumab and …
Tradipitant Relieves Nausea, Other Gastroparesis Symptoms
WEBTradipitant is efficacious for relieving nausea and other gastroparesis symptoms. Tradipitant significantly improved nausea and other symptoms in patients with idiopathic and diabetic gastroparesis compared with placebo, according to study results presented at the American College of Gastroenterology (ACG) 2022 Annual Meeting, held from October ...
Gastroparesis Awareness Month: Updated Guidelines to Treat …
WEBAug 19, 2022 · The American College of Gastroenterology (ACG) released updated clinical guidelines on managing gastroparesis (GP). The new recommendations were published in The American Journal of Gastroenterology.. GP is characterized by delayed gastric emptying (GE) of solid food in the absence of mechanical obstruction.
Evaluating GI Events With Semaglutide for Weight Loss
WEBOct 4, 2021 · Authors of an analysis of pooled data from the phase 3 Semaglutide Treatment Effect in People with obesity (STEP) 1-4 trials have concluded that the gastrointestinal (GI) adverse events (AEs) that participants reported were mild-to-moderate and did not significantly contribute to treatment discontinuation.
Gastric Intestinal Metaplasia: 2020 AGA Guidelines
WEBMar 12, 2020 · Gastric cancer (GCa) has a significant impact on worldwide morbidity and mortality as the third-leading cause of cancer death in the world. 1 It has traditionally been associated with poor outcomes and limited treatment options by the time patients clinically present. Helicobacter pylori (HP) is the primary cause of intestinal-type noncardia GCa (located in the antrum, body, incisura, or ...
Novel Drug Tradipitant Effective, Safe for Treatment of Nausea in ...
WEBOct 29, 2021 · Tradipitant appears to be an effective and safe treatment option for gastroparesis symptoms, according to research presented at the American College of Gastroenterology (ACG) 2021 Annual Meeting, held from October 22 to 27, 2021, in Las Vegas, Nevada and virtually.
Controversies in the Diagnosis and Treatment of Gastroparesis
WEBIn an editorial published by the American Journal of Gastroenterology, authors Brian E. Lacy, MD, PhD and David J. Cangemi, MD addressed common misconceptions regarding the diagnosis and treatment of gastroparesis (GP).The prevalence, etiology, and pathogenesis of GP were described, along with diagnostic techniques and prognosis.